Blood Group |
Male (N=312) |
Female (N=288) |
Total (N=600) |
|
||||||||||||
|
Absolute Value |
Frequency distribution
(%) |
Absolute Value |
Frequency distribution
(%) |
Absolute Value |
Frequency distribution
(%) |
|
|||||||||
A |
62 |
20 |
70 |
24 |
132 |
22 |
|
|||||||||
B |
124 |
40 |
120 |
42 |
244 |
41 |
|
|||||||||
AB |
42 |
13 |
32 |
11 |
74 |
12 |
|
|||||||||
O |
84 |
27 |
66 |
23 |
150 |
25 |
|
|||||||||
|
Blood group |
Control (Non Gall bladder stone
affected population) N=600 |
Study Group (Gall Bladder stone
affected population) N=100 |
||
|
Absolute Value |
Frequency (%) |
Absolute Value |
Frequency (%) |
A |
132 |
22 |
18 |
18 |
B |
244 |
41 |
26 |
26 |
AB |
74 |
12 |
8 |
8 |
O |
150 |
25 |
48 |
48 |
Rh+ |
600 |
100 |
100 |
100 |
RH- |
0 |
0 |
0 |
0 |